Aimedis (AIM)

The Future of Healthcare Supported by AI

Review Score
4.03/5
ICO Price
0.12 USD
Pre ICO Price
0.12 USD
Soft Cap
N/A
Hard Cap
600,000,000 AIM
Start Date
12 April 2018
End Date
10 May 2018

What is Aimedis?

https://youtube.com/watch?v=jwyQCXeOzEM

Aimedis is a Netherlands-based company providing an innovative next-generation healthcare solution designed to connect patients to healthcare services and providers like doctors, hospitals and scientific research facilities. While competitors exist in this space, Aimedis is the only operational platform to integrate latest blockchain technology alongside artificial intelligence (AI).

The Aimedis team has been working on multiple ehealth projects since 2009 including a solution for the pharmaceutical industry, but started its initial version of a working platform, codenamed “TheHealthNet”, focusing on the patient – doctor connection and data exchange in 2012.

The system was tested successfully in the clinical environment, forming the foundation for the development of Aimedis. Our experiences during this pilot time, combined with 11 years of clinical experience in internal medicine and neurology of the founders are integral components of the ecosystem. An ecosystem, which benefits both the patients and professionals in the medical field.

Information displayed on CoinCheckup can be updated by the respective ICOs and/or Crypto representatives and does not present the opinion of CoinCheckup.com and/or the CoinCheckup team.

Trading and investing in digital assets is highly speculative and comes with many risks. The analysis/stats on CoinCheckup.com and it’s subsites are for informational purposes and should not be considered investment advice and or the truth. Statements and financial information on CoinCheckup.com and it’s subsites should not be construed as an endorsement or recommendation to buy, sell or hold.

Please do your own research on all of your investments carefully. Scores are based on averages of third party websites.  Past performance is no indicative of future results. Read the full disclaimer here.